The new Rodger Kobes and Michael Keller Science and Human Health Lectureship at Hope College will debut with the general-audience address “Gene Therapy 101 — What you should know” by Dr. Anne Connolly ...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...

New Delhi: The Central government is set to launch a scheme to develop 12 indigenous drugs for eight rare diseases, health ...

Institutional investors interested in meeting with management during the conferences may reach out to their Chardan representatives.

GeneCQ uses integrated medical and pharmacy claims data to provide insight into the exposure to the costs for gene therapies.

WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with ...

Palermo easily held back his competition, while Victoria-Vitale clinched her overall SITRAC Triple Crown win with her victory ...

When you get told that your little brother or best friend has a problem with your their muscles, what is the first thing you ...

The biotech sector is in good shape in 2024 and looks primed for sustained growth. These ASX stocks are looking to lead the way.

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

They can be divided into the more severe Duchenne muscular dystrophy and the milder Becker muscular dystrophy. Here, we characterize the clinical, histopathological and molecular genetic aspects of ...

A large, retrospective analysis of patients with amyotrophic lateral sclerosis (ALS) and progressive muscular atrophy (PMA) indicates that a substantial proportion of PMA patients develop upper ...